To clarify the role of expectant, medical and surgical treatment in the management of spontaneous abortion.
omission of other relevant studies, and methods used to select studies were not described. Attempts were made to locate unpublished material. Validity was not formally assessed. Details of the methods used to extract data were provided, and some relevant data were presented in tabular format. Data were pooled with weighting by sample size, and the influence of study design on the results was explored. There may be a misprint in the reporting of pooled success weighted average for medical treatment, since the lower 95% CI for success of medical treatment was greater than the average. Statistical heterogeneity was not assessed, and could not be assessed from the data presented. It was, therefore, not possible to determine whether pooling the data was appropriate. The discussion includes consideration of the following limitations of the review: formal comparison of medical, surgical and expectant treatments was not possible due to the small number of RCTs identified; only three studies evaluated medical treatment; the possibility of selection bias in selecting patients who were bleeding more heavily for surgical rather than expectant treatment; and the estimated pooled weighted averages did not allow statistical comparisons between treatments.
Without an assessment of validity, the quality of the evidence on which the conclusions are based cannot be determined, and without an evaluation of heterogeneity, the generalisability of the results cannot be judged.
Implications of the review for practice and research
Practice: The authors state that expectant management of spontaneous abortion in the first trimester is safe and effective for many afebrile patients whose blood-pressure and heart rate are stable, and who have no excess bleeding or unacceptable pain. Transvaginal sonographic studies might be useful in patient selection, and serial chorionic gonadotropin monitoring should be considered while observing the initial course of expectant treatment. There is not yet sufficient evidence for medical treatment of incomplete abortion. Surgical treatment is indicated in the presence of continued brisk vaginal bleeding, infection of unacceptable pain and probably for gestation greater than 13 weeks.
Research: The authors state that further research is needed to clarify the role of surgical treatment, including comparisons of expectant treatment with surgical approaches in larger RCTs with wider inclusion criteria for transvaginal sonography cut-offs, and patient preference studies incorporating the latest research. 
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